Author(s):
Prem Kumar, Reneesh Jaiswal, Rajesh Meshram, Dheeraj Ahirwar
Email(s):
yprem173@gmail.com
DOI:
10.52711/0974-4150.2026.00016
Address:
Prem Kumar*, Reneesh Jaiswal, Rajesh Meshram, Dheeraj Ahirwar
School of Pharmacy, Chouksey Engineering College Bilaspur, Chhattisgarh, India.
*Corresponding Author
Published In:
Volume - 19,
Issue - 2,
Year - 2026
ABSTRACT:
The escalating global crisis of antimicrobial resistance (AMR) necessitates the urgent development of novel therapeutic agents. Carbazole, a privileged scaffold in medicinal chemistry, is known for its diverse biological activities. This study aimed to synthesize and characterize novel carbazole-based hydrazide derivatives and evaluate their antibacterial potential. Two target compounds, 2-(2-chloro-9H-carbazol-9-yl) acetohydrazide (IIIa) and 2-(3-bromo-9H-carbazol-9-yl) acetohydrazide (IIIb), were synthesized via a two-step procedure involving N-alkylation of substituted carbazoles with ethyl chloroacetate, followed by hydrazinolysis. The structures of the synthesized compounds were unequivocally confirmed using sophisticated spectroscopic techniques, including FTIR and ¹H NMR. The compounds were obtained in good yields (68-76%) and exhibited sharp melting points, indicating high purity. In-vitro antibacterial screening against Staphylococcus aureus (Gram-positive) and Pseudomonas aeruginosa (Gram-negative) strains revealed promising activity. Compound IIIa (Cl-substituted) showed superior potency with Minimum Inhibitory Concentration (MIC) values of 12µg/mL and 9µg/mL, respectively, compared to IIIb (Br-substituted) with MICs of 18µg/mL and 16µg/mL. The results establish a preliminary structure-activity relationship, indicating that the nature and position of the halogen substituent significantly influence antibacterial efficacy. These findings position these novel carbazole hydrazides as promising lead compounds for the development of new antimicrobial agents to combat drug-resistant bacteria.
Cite this article:
Prem Kumar, Reneesh Jaiswal, Rajesh Meshram, Dheeraj Ahirwar. Synthesis, Spectroscopic Characterization and In-Vitro Antimicrobial Evaluation of New Hydrazide-Functionalized Carbazole Derivatives. Asian Journal of Research in Chemistry.2026; 19(2):97-0. doi: 10.52711/0974-4150.2026.00016
Cite(Electronic):
Prem Kumar, Reneesh Jaiswal, Rajesh Meshram, Dheeraj Ahirwar. Synthesis, Spectroscopic Characterization and In-Vitro Antimicrobial Evaluation of New Hydrazide-Functionalized Carbazole Derivatives. Asian Journal of Research in Chemistry.2026; 19(2):97-0. doi: 10.52711/0974-4150.2026.00016 Available on: https://ajrconline.org/AbstractView.aspx?PID=2026-19-2-3
REFERENCES:
1. Murray CJ, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022; 399(10325): 629-55.
2. Naghavi M, et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199–226.
3. Bertagnolio S, et al. WHO global research priorities for antimicrobial resistance in human health. Lancet Microbe. 2024; 12(8): e117.
4. Miethke M, et al. Towards the sustainable discovery and development of new antibiotics. Nat Rev Chem. 2021; 5(9): 726-49.
5. Gigante V, Sati H, Beyer P. Recent advances and challenges in antibacterial drug development. ADMET DMPK. 2022; 10(2): 147-51.
6. Melchiorri D, et al. Addressing urgent priorities in antibiotic development: insights from WHO 2023 antibacterial clinical pipeline analyses. Lancet Microbe. 2024; 5(10): e877-81.
7. Tsutsumi LS, Gündisch D, Sun D. Carbazole scaffold in medicinal chemistry and natural products: a review from 2010–2015. Curr Top Med Chem. 2016; 16(11): 1290-313.
8. Głuszyńska A. Biological potential of carbazole derivatives. Eur J Med Chem. 2015; 94: 405-26.
9. Patil SA, et al. Carbazole derivatives as potential antimicrobial agents. Molecules. 2022; 27(19): 6575.
10. Çapan İ, et al. Synthesis of novel carbazole hydrazine-carbothioamide scaffold as potent antioxidant, anticancer, and antimicrobial agents. BMC Chem. 2024; 18(1): 102.
11. Bashir M, et al. Recent developments and biological activities of N-substituted carbazole derivatives: a review. Molecules. 2015; 20(8): 13496-517.
12. Ding YY, et al. Design, synthesis, and antimicrobial activity evaluation of novel tetrahydrocarbazole derivatives against phytopathogenic fungi and bacteria. Pest Manag Sci. 2024.
13. Salih N, Salimon J, Yousif E. Synthesis and antimicrobial activities of 9H-carbazole derivatives. Arab J Chem. 2016; 9: S781–S786.
14. Bordei Telehoiu AT, et al. Design, synthesis, and in vitro characterization of novel antimicrobial agents based on 6-chloro-9H-carbazol derivatives and 1,3,4-oxadiazole scaffolds. Molecules. 2020; 25(2): 266.
15. Hegden PR, et al. In silico design, synthesis, and biological evaluation of novel carbazole derivatives. J Pharm Sci Res. 2021; 13(1): 8-18.
16. Xue YJ, et al. Design, synthesis, and evaluation of carbazole derivatives as potential antimicrobial agents. J Enzyme Inhib Med Chem. 2021; 36(1): 295-306.
17. Zawadzka K, et al. Evaluation of the antimicrobial potential and toxicity of a newly synthesized 4-(4-(benzylamino) butoxy)-9H-carbazole. Int J Mol Sci. 2021; 22(23): 12796.
18. Shaikh MS, et al. Synthesis and biological evaluation of novel carbazole hybrids as promising antimicrobial agents. Chem Biodivers. 2020; 17(5): e1900550.
19. Kumar U, et al. Synthesis and evaluation of biological activity of some novel carbazole derivatives. Indian J Chem. 2023; 62(1): 60-4